Stay updated with breaking news from Creo l. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
19 May 2021 | 09:55am StockMarketWire.com - Medical device company Creo Medical upgraded its outlook on annual revenue after first-quarter results topped management s expectations. Revenue performance for the year ending 31 December 2021 would be at least 10% ahead of current market expectations of £20.1m, the company said. The current year has started well, with trading in the three months ended 31 March 2021 ahead of management s expectations. There has been an increase in commercial activity from Creo s core products together with strong contributions from Albyn Medical and Boucart Medical, which were acquired during 2020, it added. The strengthening of the company s commercial team, both organically under the direction of David Woods, and through acquisitions made by the Group during 2020, has been highly successful. ....
17 February 2021 | 08:11am StockMarketWire.com - Medical device company Creo Medical said annual performance was marginally ahead of management s expectation amid ongoing commerical progress thanks to a boost from acquisitions. For the year ended 31 December 2020, revenue jumped to over £9 million from £0.01 million a year earlier, with net cash position in excess of £45 million. The acquisitions of Albyn Medical S.L. and Boucart Medical SRL provided the company with a direct sales presence in Europe to facilitate the roll-out of its CE marked advanced energy devices, and strengthen Creo s EU and UK commercial teams, the company said. In 2021, the immediate focus for the company is to deliver clinical outcomes for all devices, Creo said. ....